Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response

Safae Hamkour, Eefje Hm van der Heijden, Ana P Lopes, Sofie L M Blokland, Cornelis P J Bekker, Cornelia G Van Helden-Meeuwsen, Marjan A Versnel, Aike A Kruize, Timothy Rdj Radstake, Helen L Leavis, Maarten R Hillen, Joel Ag van Roon*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

4 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response'. Together they form a unique fingerprint.

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science